Equilesterol
Natural health product licensed in Canada
- Licence holder
- Prohealth Centre Inc.
- NPN or DIN-HM
- 80075019
- Status
- Active licence
- Licence date
- 13 January 2017
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Glucomannane Source : Amorphophallus konjac - tubercule | 250 milligramme | Not calculated |
| Stérols végétaux libres Source : Glycine max - Graine Potency : 80 % Combined beta-Sitosterol, Campesterol and Stigmasterol | 265 milligramme | Not calculated |
Non-medicinal ingredients
Hypromellose, Stéarate de magnésium, Cellulose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2 Capsule | 3 days |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps to lower cholesterol levels (by reducing cholesterol absorption from the gastrointestinal tract). Used in Herbal Medicine as a bulk-forming laxative. Used in Herbal Medicine to promote bowel movements by increasing bulk volume and water content. Used in Herbal Medicine to provide gentle relief of constipation and/or irregularity. Helps lower blood total and LDL cholesterol. Helps maintain healthy cholesterol levels.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
Do not use if you have difficulty swallowing.
- Effets indésirables connus
If you experience chest pain, vomiting, or difficulty swallowing or breathing after taking the product, seek immediate medical attention. Loose stools, flatulence, diarrhea, and abdominal discomfort have been reported.
- Précautions et mises en garde
Consult a health care practitioner prior to use if you are pregnant or breastfeeding. Consult a health care practitioner prior to use if you have diabetes. Consult a health care practitioner if symptoms worsen or if laxative effect does not occur within 7 days. Consult a health care practitioner prior to use if you have symptoms such as abdominal pain, nausea, vomiting or fever (as these could be signs of abnormal constrictions of the gastrointestinal tract, diseases of the oesophagus and/or the superior opening of the stomach (cardia), potential or existing intestinal blockage, paralysis of the intestine, megacolon, faecal impaction, inflamed bowel or appendicitis).
Source
Official Health Canada record, licence 80075019
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.